Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

False Claims Act: US Justice Department Gives Pharma Early Christmas Present

Executive Summary

Government seeks dismissal of 10 qui tam complaints related to pharma reimbursement support services, asserting the lawsuits were brought by a ‘professional’ whistleblower and lack merit.

Advertisement

Related Content

Will US Government Pursue Fewer False Claims Act Cases In 2019?
US False Claims Act Dismissal Motions Are Executive Branch Over-Reach, Whistleblowers Say
US Enforcement 2019: Compounding, Opioids Top Priorities But Beware Of REMS Violations, Too
Pharma May See Brighter Enforcement Environment After US Justice Department Policy Changes
Gilead False Claims Case: Government Opposes Supreme Court Review But Thinks Suit Should Be Tossed
Government Pharma Investigations Target Pricing, Opioids, Trade Practices

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel